ISV Mini-Symposia

ISV’s Influenza Mini-Symposium

- Glenda Gray – Why HIV Vaccines Are Still Needed
- William Schief – Clinical Progress Toward Vaccine Induction of HIV Broadly Neutralizing Antibodies
- Peter Gilbert – Immune Correlates of Protection for HIV Vaccines
- Shan Lu – The Progress of Polyvalent DNA Prime and Protein Boost HIV Vaccine (PDPHV)

Recording is available here.

Title: Mini-Symposium on RSV Vaccines
Date: April 24th
Presenters:
- Global Lifelong Burden of RSV – Louis Bont, M.D., Ph.D, Professor, University Medical Center Utrecht
- Prefusion-F Stability and Vaccine Efficacy: Structure-Based Vaccines for RSV/HMPV/PIV – Peter Kwong, Ph.D, Richard J. Stock Professor, Biochemistry and Molecular Biophysics Columbia University
- PIV5-vectored RSV Intranasal Vaccine (BLB201) is Safe and Immunogenic in Healthy Adults and Young Children, Hong Jin, Ph.D, Chief Scientific Officer, CynVac/Blue Lake Bio
- RSVPreF Vaccine in Older Adults and At-Risk Adults Aged 18 – 59 Years – Kumar Ilangovan, MD, MSPH, MMCi, FACP, FAAP, Director, Vaccines Clinical Research & Global Clinical Lead, RSV Adult Vaccine Program, Pfizer Vaccine
Recording is available here.

Title: Mini-Symposium on Pneumococcal Vaccines
Date: Thursday, January 30th
Presenters:
- Kathleen McElwee, Pfizer
- Stefanie Desmet, UZ Leuve
- Norman Baylor, Sabin Vaccine Institute
- Cynthia Whitney, Cynthia Whitney
Recording is available here.